PatientsVille.com Logo

Olopatadine Side Effects

PatientsVille

Common Olopatadine Side Effects


The most commonly reported Olopatadine side effects (click to view or check a box to report):

Hepatic Function Abnormal (3)
Aspartate Aminotransferase Increased (3)
Circulatory Collapse (2)
Alanine Aminotransferase Increased (2)
Haematocrit Increased (2)
Dizziness (2)
Pyrexia (2)
Arrhythmia (2)
White Blood Cell Count Increased (2)
Blood Pressure Decreased (2)
Cardiac Arrest (2)
Malaise (2)
Bradycardia (2)
Blood Creatinine Increased (2)
Arthralgia (1)
Apraxia (1)
Asthenia (1)
Constipation (1)
Psychotic Disorder (1)
Autonomic Neuropathy (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Olopatadine Side Effects Reported to FDA



Olopatadine Side Effect Report#8849055
Anosmia
This is a report of a 56-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: seasonal allergic rhinitis, who was treated with Olopatadine (dosage: 2 Spray In Each Postril, start time:
Oct 01, 2012), combined with: NA. and developed a serious reaction and side effect(s): Anosmia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Olopatadine treatment in female patients, resulting in Anosmia side effect.
Olopatadine Side Effect Report#8453938-2
Renal Impairment
This report suggests a potential Olopatadine Hcl Renal Impairment side effect(s) that can have serious consequences. A 42-year-old male patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: NA and used Olopatadine Hcl (dosage: Unk) starting
Apr 12, 2012. After starting Olopatadine Hcl the patient began experiencing various side effects, including: Renal ImpairmentAdditional drugs used concurrently:
  • Lipitor
  • Diovan (Unk)
  • Allegra (Unk)
Although Olopatadine Hcl demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Renal Impairment, may still occur.
Olopatadine Side Effect Report#8389910-0
Blood Potassium Increased, Renal Disorder, Haemoglobin Decreased, Acute Respiratory Failure, Blood Creatinine Increased, Haematocrit Decreased, Blood Alkaline Phosphatase Increased, Blood Urea Increased
This Blood Potassium Increased problem was reported by a consumer or non-health professional from Japan. A 78-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Dec 16, 2011 this consumer started treatment with Olopatadine Hcl (dosage: NA). The following drugs were being taken at the same time:
  • Lansoprazole
  • Loxonin
  • Glufast
  • Antebate
  • Prednisolone
  • Prednisolone
  • Zolinza (400 Mg/daily Po, 100 Mg/daily Po, 200 Mg/daily Po)
  • Zolinza (400 Mg/daily Po, 100 Mg/daily Po, 200 Mg/daily Po)
When using Olopatadine Hcl, the patient experienced the following unwanted symptoms/side effects: Blood Potassium Increased, Renal Disorder, Haemoglobin Decreased, Acute Respiratory Failure, Blood Creatinine Increased, Haematocrit Decreased, Blood Alkaline Phosphatase Increased, Blood Urea IncreasedAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Blood Potassium Increased, may become evident only after a product is in use by the general population.
Olopatadine Side Effect Report#8385896-3
Toxic Skin Eruption
This Toxic Skin Eruption side effect was reported by a physician from Japan. A 69-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Olopatadine Hcl (drug dosage: NA), which was initiated on
Mar 14, 2012. Concurrently used drugs:
  • Galantamine Hydrobromide
  • Aspirin Dialuminate
  • Norvasc
.After starting to take Olopatadine Hcl the consumer reported adverse symptoms, such as: Toxic Skin EruptionThese side effects may potentially be related to Olopatadine Hcl.
Olopatadine Side Effect Report#8334843-9
Aggression, Suicide Attempt
This is a report of a 39-year-old female patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: seasonal allergy, who was treated with Olopatadine Hcl (dosage: Unk, start time:
Oct 01, 2011), combined with:
  • Litiomal
  • Clonazepam
  • Goodmin
  • Yaz (1 Df, Qd)
  • Eticalm
and developed a serious reaction and side effect(s): Aggression, Suicide Attempt after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Olopatadine Hcl treatment in female patients, resulting in Aggression side effect.
Olopatadine Side Effect Report#8323395-5
Juvenile Arthritis, Hepatic Function Abnormal
This report suggests a potential Olopatadine Hcl Juvenile Arthritis side effect(s) that can have serious consequences. A female patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: rhinitis allergic and used Olopatadine Hcl (dosage: NA) starting
Sep 17, 2011. After starting Olopatadine Hcl the patient began experiencing various side effects, including: Juvenile Arthritis, Hepatic Function AbnormalAdditional drugs used concurrently:
  • Methotrexate
  • Folic Acid
  • Prednisolone
  • Methotrexate
  • Adalimumab
  • Lansoprazole
  • Adalimumab
  • Prednisolone (15-30 Mg/day)
The patient was hospitalized. Although Olopatadine Hcl demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Juvenile Arthritis, may still occur.
Olopatadine Side Effect Report#8125354-4
Haematocrit Increased, Leukocytosis, Chronic Myeloid Leukaemia
This Haematocrit Increased problem was reported by a physician from Japan. A male patient (weight: NA) was diagnosed with the following symptoms/conditions: rhinitis allergic,gastrooesophageal reflux disease,right ventricular failure. On
Jan 01, 1996 this consumer started treatment with Olopatadine Hcl (dosage: 10mg Per Day). The following drugs were being taken at the same time:
  • Rabeprazole Sodium (10mg Per Day)
  • Torsemide (8mg Per Day)
  • Lisinopril (10mg Per Day)
  • Ethyl Icosapentate (1800mg Per Day)
  • Allopurinol (100mg Per Day)
  • Flolan
When using Olopatadine Hcl, the patient experienced the following unwanted symptoms/side effects: Haematocrit Increased, Leukocytosis, Chronic Myeloid LeukaemiaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Haematocrit Increased, may become evident only after a product is in use by the general population.
Olopatadine Side Effect Report#8105502-2
Loss Of Consciousness, Nausea, Vomiting
This Loss Of Consciousness side effect was reported by a physician from Japan. A 69-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Olopatadine Hcl (drug dosage: 10 Mg, 1x/day), which was initiated on
Jan 11, 2012. Concurrently used drugs:
  • Lyrica (50 Mg, 2x/day)
  • Mucodyne (1000 Mg, 1x/day)
  • Cleanal (400 Mg, 1x/day)
.After starting to take Olopatadine Hcl the consumer reported adverse symptoms, such as: Loss Of Consciousness, Nausea, VomitingThese side effects may potentially be related to Olopatadine Hcl. The patient was hospitalized.
Olopatadine Side Effect Report#8065380-7
Hepatic Neoplasm Malignant, Pyrexia, Neutrophil Count Increased, Hepatic Function Abnormal, Insomnia, Hypertension, Constipation
This is a report of a 54-year-old male patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: NA, who was treated with Olopatadine Hcl (dosage: Daily Dose 10 Mg, start time:
Oct 29, 2011), combined with:
  • Atarax (Daily Dose 50 Mg)
  • Nexavar (400 Mg, Qd)
  • Lansoprazole (Daily Dose 15 Mg)
  • Hirudoid (Unk)
and developed a serious reaction and side effect(s): Hepatic Neoplasm Malignant, Pyrexia, Neutrophil Count Increased, Hepatic Function Abnormal, Insomnia, Hypertension, Constipation after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Olopatadine Hcl treatment in male patients, resulting in Hepatic Neoplasm Malignant side effect.
Olopatadine Side Effect Report#8029858-4
Blood Glucose Increased
This report suggests a potential Olopatadine Hcl Blood Glucose Increased side effect(s) that can have serious consequences. A 73-year-old male patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: NA and used Olopatadine Hcl (dosage: NA) starting
Nov 02, 2011. After starting Olopatadine Hcl the patient began experiencing various side effects, including: Blood Glucose IncreasedAdditional drugs used concurrently:
  • Antithrombotic Agents
  • Coniel
  • Plavix
  • Anplag
  • Aspirin
  • Basen
  • Anplag
  • Tricor
The patient was hospitalized. Although Olopatadine Hcl demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Blood Glucose Increased, may still occur.
Olopatadine Side Effect Report#8018605-8
Blood Albumin Decreased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Epstein-barr Virus Antibody Positive, Faeces Pale, Allergic Hepatitis, Prothrombin Time Prolonged, Malaise, Prothrombin Time Ratio Decreased
This Blood Albumin Decreased problem was reported by a physician from Japan. A 81-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: pruritus. On
Nov 14, 2011 this consumer started treatment with Olopatadine Hcl (dosage: NA). The following drugs were being taken at the same time:
  • Atarax
  • Xyzal
  • Celestamine Tab
When using Olopatadine Hcl, the patient experienced the following unwanted symptoms/side effects: Blood Albumin Decreased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Epstein-barr Virus Antibody Positive, Faeces Pale, Allergic Hepatitis, Prothrombin Time Prolonged, Malaise, Prothrombin Time Ratio DecreasedThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Blood Albumin Decreased, may become evident only after a product is in use by the general population.
Olopatadine Side Effect Report#8007206-3
Laceration
This Laceration side effect was reported by a pharmacist from Japan. A 71-year-old female patient (weight:NA) experienced the following symptoms/conditions: pruritus.The patient was prescribed Olopatadine Hcl (drug dosage: 5 Mg, 2x/day), which was initiated on NS. Concurrently used drugs:
  • Hirudoid (Unk)
  • Drenison (Unk)
  • Lipitor (10 Mg, Uid/qd)
.After starting to take Olopatadine Hcl the consumer reported adverse symptoms, such as: LacerationThese side effects may potentially be related to Olopatadine Hcl.
Olopatadine Side Effect Report#7912392-7
Pain, Myocardial Infarction, Cerebrovascular Accident, Pulmonary Embolism, Anxiety, Gallbladder Disorder, Deep Vein Thrombosis, Cholecystitis Acute, Cholecystitis Chronic
This is a report of a 25-year-old female patient (weight: NA) from United States, suffering from the following health symptoms/conditions: NA, who was treated with Olopatadine Hydrochloride (dosage: Unk Unk, Prn, start time:
Jan 01, 2001), combined with:
  • Xanax (Unk)
  • Drospirenone And Ethinyl Estradiol (Unk)
  • Prednisone (Unk)
  • Pepcid (Unk Unk, Qd)
  • Yasmin (Unk)
  • Advair Diskus 100/50 (Unk)
  • Allegra
  • Flonase
and developed a serious reaction and side effect(s): Pain, Myocardial Infarction, Cerebrovascular Accident, Pulmonary Embolism, Anxiety, Gallbladder Disorder, Deep Vein Thrombosis, Cholecystitis Acute, Cholecystitis Chronic after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Olopatadine Hydrochloride treatment in female patients, resulting in Pain side effect.
Olopatadine Side Effect Report#7850789-4
Dyspnoea, Burning Sensation
This report suggests a potential Olopatadine Hydrochloride Dyspnoea side effect(s) that can have serious consequences. A male patient (weight: NA) from United States was diagnosed with the following symptoms/conditions: hypersensitivity and used Olopatadine Hydrochloride (dosage: NA) starting NS. After starting Olopatadine Hydrochloride the patient began experiencing various side effects, including: Dyspnoea, Burning SensationAdditional drugs used concurrently:
  • Fluticasone Propionate
  • Proair Hfa
Although Olopatadine Hydrochloride demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Dyspnoea, may still occur.
Olopatadine Side Effect Report#7833499-9
Pulmonary Artery Thrombosis, Venous Thrombosis
This Pulmonary Artery Thrombosis problem was reported by a physician from Japan. A 29-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: pruritus,non-small cell lung cancer,constipation. On
Sep 21, 2010 this consumer started treatment with Olopatadine Hcl (dosage: 1 Tablet, As Needed). The following drugs were being taken at the same time:
  • Crizotinib (250 Mg, 2x/day)
  • Milmag (2 Tablets, As Needed)
  • Kindavate (As Needed)
When using Olopatadine Hcl, the patient experienced the following unwanted symptoms/side effects: Pulmonary Artery Thrombosis, Venous ThrombosisThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Pulmonary Artery Thrombosis, may become evident only after a product is in use by the general population.
Olopatadine Side Effect Report#7817466-7
Jaw Disorder, Paralysis, Viith Nerve Paralysis, Apraxia, Tenderness, Cranial Nerve Palsies Multiple, Temporomandibular Joint Syndrome, Dysphagia, Trismus
This Jaw Disorder side effect was reported by a physician from Japan. A 75-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Olopatadine Hcl (drug dosage: NA), which was initiated on
Sep 02, 2011. Concurrently used drugs:
  • Mucosta
  • Cefazolin Sodium (Dosage Form: Powder)
  • Methaderm
  • Ferrum
  • Xyzal
  • Tranexamic Acid
  • Xyzal
  • Bio-three
.After starting to take Olopatadine Hcl the consumer reported adverse symptoms, such as: Jaw Disorder, Paralysis, Viith Nerve Paralysis, Apraxia, Tenderness, Cranial Nerve Palsies Multiple, Temporomandibular Joint Syndrome, Dysphagia, TrismusThese side effects may potentially be related to Olopatadine Hcl. The patient was hospitalized and became disabled.
Olopatadine Side Effect Report#7814212-8
Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Hepatic Function Abnormal
This is a report of a 71-year-old male patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: NA, who was treated with Olopatadine Hcl (dosage: NA, start time:
Aug 17, 2006), combined with:
  • Allopurinol
  • Arava
  • Uralyt
  • Azulfidine
  • Flivas
  • S. Adchnon
  • Comelian
and developed a serious reaction and side effect(s): Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Hepatic Function Abnormal after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Olopatadine Hcl treatment in male patients, resulting in Aspartate Aminotransferase Increased side effect. The patient was hospitalized.
Olopatadine Side Effect Report#7802479-1
White Blood Cell Count Increased, Haematocrit Increased
This report suggests a potential Olopatadine Hcl White Blood Cell Count Increased side effect(s) that can have serious consequences. A male patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: rhinitis allergic,pulmonary arterial hypertension,hyperuricaemia,right ventricular failure,dyslipidaemia and used Olopatadine Hcl (dosage: 10mg Per Day) starting
Jul 02, 2009. After starting Olopatadine Hcl the patient began experiencing various side effects, including: White Blood Cell Count Increased, Haematocrit IncreasedAdditional drugs used concurrently:
  • Flolan
  • Allopurinol (100mg Per Day)
  • Torsemide (8mg Per Day)
  • Ethyl Icosapentate (1800mg Per Day)
  • Lisinopril (10mg Per Day)
  • Rabeprazole Sodium (10mg Per Day)
Although Olopatadine Hcl demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as White Blood Cell Count Increased, may still occur.
Olopatadine Side Effect Report#7777138-4
Thyroid Cancer
This Thyroid Cancer problem was reported by a physician from Japan. A 37-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Feb 09, 2011 this consumer started treatment with Olopatadine Hcl (dosage: NA). The following drugs were being taken at the same time:
  • Solostar
  • Metformin Hydrochloride (2 Tab Each After Breakfast And Supper)
  • Lantus
  • Lantus
  • Exenatide
  • Metformin Hydrochloride (After Breakfast)
  • Lantus
  • Metformin Hydrochloride (1 Tab Each After Breakfast And Supper)
When using Olopatadine Hcl, the patient experienced the following unwanted symptoms/side effects: Thyroid CancerAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Thyroid Cancer, may become evident only after a product is in use by the general population.
Olopatadine Side Effect Report#7704364-2
Dermatitis Bullous
This Dermatitis Bullous side effect was reported by a physician from Japan. A 66-year-old female patient (weight:NA) experienced the following symptoms/conditions: hypersensitivity,hypertension.The patient was prescribed Olopatadine Hcl (drug dosage: NA), which was initiated on
Jan 01, 2005. Concurrently used drugs:
  • Cozaar
  • Carvedilol
  • Mucosta
.After starting to take Olopatadine Hcl the consumer reported adverse symptoms, such as: Dermatitis BullousThese side effects may potentially be related to Olopatadine Hcl.
Olopatadine Side Effect Report#7585927-4
Thrombotic Cerebral Infarction, Decreased Appetite
This is a report of a 77-year-old female patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: pruritus, who was treated with Olopatadine Hcl (dosage: 10 Mg, Qd, start time:
May 28, 2011), combined with:
  • Victoza (0.6 Mg, Qd)
  • Victoza (0.9 Mg, Qd)
  • Amaryl (3 Mg, Qd)
  • Lasix (20 Mg, Qd)
  • Norvasc (5 Mg, Qd)
  • Sunrythm (75 Mg, Qd)
  • Digoxin (0.125 Mg, Qd)
  • Preran (1 Mg, Qd)
and developed a serious reaction and side effect(s): Thrombotic Cerebral Infarction, Decreased Appetite after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Olopatadine Hcl treatment in female patients, resulting in Thrombotic Cerebral Infarction side effect. The patient was hospitalized.
Olopatadine Side Effect Report#7561801-4
Aspartate Aminotransferase Increased, Hypersensitivity, Alanine Aminotransferase Increased, Eczema Asteatotic, Lymphocyte Count Decreased, Blood Amylase Increased, Rash, Blood Creatinine Increased
This report suggests a potential Olopatadine Aspartate Aminotransferase Increased side effect(s) that can have serious consequences. A male patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: NA and used Olopatadine (dosage: NA) starting
Dec 27, 2010. After starting Olopatadine the patient began experiencing various side effects, including: Aspartate Aminotransferase Increased, Hypersensitivity, Alanine Aminotransferase Increased, Eczema Asteatotic, Lymphocyte Count Decreased, Blood Amylase Increased, Rash, Blood Creatinine IncreasedAdditional drugs used concurrently:
  • Granisetron Hcl
  • Prednisolone
  • Levofloxacin
  • Famotidine
  • Bendamustine Hcl
  • Difluprednate
  • Brotizolam
  • Bendamustine Hcl
The patient was hospitalized. Although Olopatadine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Aspartate Aminotransferase Increased, may still occur.
Olopatadine Side Effect Report#7554037-4
Hepatitis Acute
This Hepatitis Acute problem was reported by a physician from Japan. A 22-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Olopatadine Hcl (dosage: NA). The following drugs were being taken at the same time:
  • Allegra
When using Olopatadine Hcl, the patient experienced the following unwanted symptoms/side effects: Hepatitis AcuteThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Hepatitis Acute, may become evident only after a product is in use by the general population.
Olopatadine Side Effect Report#7357691-5
Product Formulation Issue, Bone Pain, Asthenia, Viral Infection
This Product Formulation Issue side effect was reported by a consumer or non-health professional from United States. A 54-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Olopatadine (drug dosage: NA), which was initiated on
Jun 01, 2010. Concurrently used drugs:
  • Aspirin
  • Lasix
  • Prolastin-c (5900 Mg, Qw, Iv)
  • Prolastin
  • Albuterol
  • Xanax
  • Advair Diskus 100/50
.After starting to take Olopatadine the consumer reported adverse symptoms, such as: Product Formulation Issue, Bone Pain, Asthenia, Viral InfectionThese side effects may potentially be related to Olopatadine.
Olopatadine Side Effect Report#7315620-4
White Blood Cell Count Increased, Pain Of Skin, Pyrexia, Mobility Decreased, Arthralgia, Hyperuricaemia, C-reactive Protein Increased, Erythrodermic Psoriasis
This is a report of a 51-year-old male patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: dermatitis exfoliative,reflux oesophagitis,hypertension, who was treated with Olopatadine Hydrochloride (dosage: NA, start time:
Nov 24, 2005), combined with:
  • Lansoprazole
  • Enalapril Maleate
  • White Petroleum (Qs)
  • Carvedilol
  • Heparin (Qs)
  • Metenolone
  • Betamethasone Sodium Phosphate (Qs)
  • Ofloxacin (Qs)
and developed a serious reaction and side effect(s): White Blood Cell Count Increased, Pain Of Skin, Pyrexia, Mobility Decreased, Arthralgia, Hyperuricaemia, C-reactive Protein Increased, Erythrodermic Psoriasis after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Olopatadine Hydrochloride treatment in male patients, resulting in White Blood Cell Count Increased side effect. The patient was hospitalized.


1 of 2 


The appearance of Olopatadine on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

Ask a Doctor Online
12 Doctors are Online.
A Question is Answered Every 9 Seconds!
Ask a Doctor >

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Olopatadine reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Ask a Doctor Online
    12 Doctors are Online.
    A Question is Answered Every 9 Seconds!
    Ask a Doctor >

    Discuss Olopatadine Side Effects

    Did You Have a Olopatadine Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Olopatadine for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Olopatadine Safety Alerts, Active Ingredients, Usage Information

    More About Olopatadine

    Side Effects reported to FDA: 28

    Olopatadine safety alerts: No

    Reported deaths: 2

    Reported hospitalizations: 13

    Latest Olopatadine clinical trials

    Olopatadine Reviews

    No reviews, be a first to report a side effect via side effect reporting form